Methanol


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
1410 CRYAB Increases expression PMID:22257634
1412 CRYBA2 Increases expression PMID:22257634
1417 CRYBB3 Increases expression PMID:22257634
1437 CSF2 Increases expression PMID:11306435
1535 CYBA Increases expression PMID:25726414
17907 MYLPF Increases expression PMID:22257634
2099 ESR1 Increases expression PMID:15659783
2597 GAPDH Decreases expression PMID:22257634
3217 HOXB7 Increases expression PMID:31711903
3219 HOXB9 Increases expression PMID:31711903
3329 HSPD1 Decreases expression PMID:22257634
3565 IL4 Decreases expression PMID:19145326
3897 L1CAM Decreases activity PMID:29109170
43 ACHE Decreases activity PMID:16129618; PMID:17580119; PMID:17673349
4632 MYL1 Increases expression PMID:22257634
4744 NEFH Affects expression PMID:22954530
498 ATP5F1A Decreases expression PMID:22257634
5957 RCVRN Decreases expression PMID:22257634
63973 NEUROG2 Increases expression PMID:31711903
6620 SNCB Decreases expression PMID:22257634
79054 TRPM8 Increases activity PMID:24133248
DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.